Teva Pharma
Teva Pharma
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Bicalutamide and Abemaciclib in Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast Cancer | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Kennedy disease, Neoplasms by Site, Skin and Connective Tissue Diseases, X-linked disease, breast disorder, breast neoplasm, central nervous system disorder, hereditary disease, inherited neurodegenerative disorder, motor neuron disorder, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, skin disorder, spinal cord disorder, spinal muscular atrophy, triple-negative breast carcinoma | Recruiting | Phase 2 | 2026-04-01 | NCT06365788 |